相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Economic Burden of Dengue
Duane J. Gubler
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
Adenovirus Delivered Short Hairpin RNA Targeting a Conserved Site in the 5′ Non-Translated Region Inhibits All Four Serotypes of Dengue Viruses
Anil Babu Korrapati et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
A highly sensitive and specific time resolved fluorometric bridge assay for antibodies to HIV-1 and -2
Sheikh M. Talha et al.
JOURNAL OF VIROLOGICAL METHODS (2011)
Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen
Heinrich Luensdorf et al.
MICROBIAL CELL FACTORIES (2011)
Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs
Boris Pastorino et al.
ANTIVIRAL RESEARCH (2010)
Strategies for development of dengue virus inhibitors
Christian G. Noble et al.
ANTIVIRAL RESEARCH (2010)
Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies
Gaurav Batra et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity
Saima Khanam et al.
VACCINE (2009)
Evaluation of Two New Commercial Tests for the Diagnosis of Acute Dengue Virus Infection Using NS1 Antigen Detection in Human Serum
Philippe Dussart et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes
Soila Sukupolvi-Petty et al.
JOURNAL OF VIROLOGY (2007)
Virus-like particles-flexible platforms for vaccine development
Bryce Chackerian
EXPERT REVIEW OF VACCINES (2007)
Serological differentiation of infections with dengue virus serotypes 1 to 4 by using recombinant antigens
D Ludolfs et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells
WD Crill et al.
JOURNAL OF VIROLOGY (2001)
分享论文
